“Full swing”: New analysis shows three respiratory viruses (including COVID) on the rise in the U.S.

It may sound a little gross, but analyzing wastewater for traces of diseases is one of the best ways to understand how populations are handling illness. It is can be a gold mine of information regarding the prevalence of respiratory viruses like influenza, respiratory syncytial virus (RSV) and SARS-CoV-2 (which causes COVID-19)....

Originally posted on salon.com

COVID is still killing 1,000 Americans per week while hospitalizations rise, CDC reports

Recent data from the Centers for Disease Control and Prevention (CDC) clearly indicates the COVID-19 pandemic is not done with us, as almost all metrics related to the SARS-CoV-2 virus (test positivity, ER visits, hospitalizations and wastewater signal) have been steadily rising for weeks. Deaths, which typically lag behind these statistics anyway, have stayed unchanged over the past week, but have still averaged over 1,000 deaths weekly for the last several weeks....

Originally posted on salon.com

Pfizer is more than doubling the cost of COVID drug Paxlovid to $1,390 per course

Pfizer — the American pharmaceutical company that helped manufacture the COVID-19 vaccine — announced on Wednesday that it is hiking the price of its antiviral drug Paxlovid to $1,390 per course, starting in 2024. In a story first reported by The Wall Street Journal, a company spokesman confirmed that Pfizer plans on more than doubling the $529 that the federal government paid for Paxlovid....

Originally posted on salon.com